MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel. This evidence concerns the gene ARRDC3 and esophageal squamous cell carcinoma.